From @Breakingviews: CureVac’s value halved to $10 billion after it said its COVID-19 vaccine may only be 47% effective. Separate trials on its cancer vaccine will be key to the German drugmaker’s future health, writes @aimeedonnellan https://t.co/BLJ5yau8zt— Reuters (@Reuters) June 17, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


